SAT-624 To determine whether a 2024 CE initiative had a positive impact on the number of patients who receive a timely diagnosis/screening and treatment plan for Type 1 Diabetes (T1D)

Abstract Disclosure: R. Allen: None. D. Dasilva: None. T. Bregartner: None. L. Welch: None. M. Mays-Verman: None. Goal: To determine whether a 2024 CE initiative had a positive impact on the number of patients who receive a timely diagnosis/screening and treatment plan for Type 1 Diabetes (T1D)Methods: Med Learning Group (MLG) conducted 218 CE activities in 2024 as part of an educational initiative supported by an independent educational grant from Sanofi. The DETECT T1D educational initiative focused on the use of early screening protocols and utilizing screening results to guide treatment approaches. Learners in each activity completed pre-/post-tests to determine changes in learners’ knowledge and competence. MLG will work with IQVIA on an analysis of claims data from pre- and post-education to identify changes in the use of recommended screening protocols among learners compared to a carefully matched control group. Control match criteria will include geography, specialty, and screening behavior. Results will be available in advance of ENDO. Results: Learners achieved gains in the recognition of the clinical presentations of T1D (46%), identification of antibody screening strategies for T1D (47%), and knowledge of the efficacy and safety of new and emerging treatments (46%) based on pre-/post-test questions (N=4804). Learners also demonstrated a 43% and 63% improvement respectively in ability to interpret results from screening protocols and to implement strategies for clinical monitoring and early screening of at-risk individuals. Results from the IQVIA claims data will demonstrate whether the education increased the screening of patients for T1D. Conclusion: Learners enhanced their knowledge and competence concerning the timely diagnosis/screening and management of T1D. Claims data will demonstrate whether the education changed practice behavior. Presentation: Saturday, July 12, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.1150
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SAT-624 To determine whether a 2024 CE initiative had a positive impact on the number of patients who receive a timely diagnosis/screening and treatment plan for Type 1 Diabetes (T1D)

RUSSIE ALLEN, Daniel Dasilva, Tom Bregartner, LAUREN K. WELCH et al.
Journal of the Endocrine Society
Diabetes Management and Research
article

SAT-624 To determine whether a 2024 CE initiative had a positive impact on the number of patients who receive a timely diagnosis/screening and treatment plan for Type 1 Diabetes (T1D)

RUSSIE ALLEN, Daniel Dasilva, Tom Bregartner, LAUREN K. WELCH, Marissa Mays-Verman
article en

Abstract

Abstract Disclosure: R. Allen: None. D. Dasilva: None. T. Bregartner: None. L. Welch: None. M. Mays-Verman: None. Goal: To determine whether a 2024 CE initiative had a positive impact on the number of patients who receive a timely diagnosis/screening and treatment plan for Type 1 Diabetes (T1D)Methods: Med Learning Group (MLG) conducted 218 CE activities in 2024 as part of an educational initiative supported by an independent educational grant from Sanofi. The DETECT T1D educational initiative focused on the use of early screening protocols and utilizing screening results to guide treatment approaches. Learners in each activity completed pre-/post-tests to determine changes in learners’ knowledge and competence. MLG will work with IQVIA on an analysis of claims data from pre- and post-education to identify changes in the use of recommended screening protocols among learners compared to a carefully matched control group. Control match criteria will include geography, specialty, and screening behavior. Results will be available in advance of ENDO. Results: Learners achieved gains in the recognition of the clinical presentations of T1D (46%), identification of antibody screening strategies for T1D (47%), and knowledge of the efficacy and safety of new and emerging treatments (46%) based on pre-/post-test questions (N=4804). Learners also demonstrated a 43% and 63% improvement respectively in ability to interpret results from screening protocols and to implement strategies for clinical monitoring and early screening of at-risk individuals. Results from the IQVIA claims data will demonstrate whether the education increased the screening of patients for T1D. Conclusion: Learners enhanced their knowledge and competence concerning the timely diagnosis/screening and management of T1D. Claims data will demonstrate whether the education changed practice behavior. Presentation: Saturday, July 12, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Medgar Evers College (US), New York Child Learning Institute (US)
Openalex Percentile: Top 59%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.